Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



St. Jude Medical Buys Endosense for up to $331 Million

Saint Paul, Minn.-based St. Jude Medical (NYSE: STJ  ) has a new subsidiary. On Monday, St. Jude announced that it has acquired Switzerland's Endosense SA, a pioneer in measuring contact force in catheter ablation, for a purchase price of $170 million up-front plus the potential for up to $161 million in subsequent milestone payments.

Exclusive of these costs, St. Jude does not expect the acquisition to affect its current-year earnings either positively or negatively.

In its press release, St. Jude quoted Mount Sinai Hospital professor Dr. Vivek Reddy as saying that Endosense's force-sensing technology "is a tremendous advancement in cardiac ablation that will potentially improve safety and efficacy, likely becoming a standard for all cardiac ablations." St. Jude further quoted Reddy as saying that in buying Endosense and its TactiCath irrigated ablation catheter, St. Jude Medical now has "a best-in-class ablation catheter."

The medical device maker said Endosense developed the TactiCath irrigated ablation catheter to give physicians an objective measure of the force they apply to the heart wall during a catheter ablation procedure. The irregular heartbeat could recur if too little force is applied, and too much force carries a risk of tissue injury, which can lead to serious complications.

St. Jude itself further noted that "the acquisition of Endosense is highly complementary to the St. Jude Medical business" and "further strengthens our industry-leading portfolio of products to treat patients with cardiac arrhythmias, and provides an opportunity to accelerate our market share capture in the $900 million global cardiac ablation catheter market."

-- Material from The Associated Press was used in this report.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2600793, ~/Articles/ArticleHandler.aspx, 10/1/2016 3:31:07 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 6 hours ago Sponsored by:
DOW 18,308.15 164.70 0.91%
S&P 500 2,168.27 17.14 0.80%
NASD 5,312.00 42.85 0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 4:05 PM
STJ $79.76 Up +0.80 +1.01%
St. Jude Medical CAPS Rating: **